FDA
approval
· 2022-11-01
FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approves a supplemental application for oxcarbazepine submitted by Amneal Pharmaceuticals LLC for the generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)